位置:首页 > 蛋白库 > NCAP_BRSVA
NCAP_BRSVA
ID   NCAP_BRSVA              Reviewed;         391 AA.
AC   P22677; Q77KZ2; Q77L02;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   23-FEB-2022, entry version 84.
DE   RecName: Full=Nucleoprotein;
DE            Short=Protein N;
DE   AltName: Full=Nucleocapsid protein;
GN   Name=N;
OS   Bovine respiratory syncytial virus (strain A51908) (BRS).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC   Monjiviricetes; Mononegavirales; Pneumoviridae; Orthopneumovirus.
OX   NCBI_TaxID=11247;
OH   NCBI_TaxID=9913; Bos taurus (Bovine).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1984667; DOI=10.1016/0042-6822(91)90057-i;
RA   Samal S.K., Zamora M., McPhillips T.H., Mohanty S.B.;
RT   "Molecular cloning and sequence analysis of bovine respiratory syncytial
RT   virus mRNA encoding the major nucleocapsid protein.";
RL   Virology 180:453-456(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=A51908, and ATCC 51908;
RX   PubMed=11724268; DOI=10.1023/a:1011888019966;
RA   Yunus A.S., Khattar S.K., Collins P.L., Samal S.K.;
RT   "Rescue of bovine respiratory syncytial virus from cloned cDNA: entire
RT   genome sequence of BRSV strain A51908.";
RL   Virus Genes 23:157-164(2001).
RN   [3]
RP   INTERACTION WITH THE PHOSPHOPROTEIN.
RX   PubMed=8609467; DOI=10.1099/0022-1317-77-5-1019;
RA   Mallipeddi S.K., Lupiani B., Samal S.K.;
RT   "Mapping the domains on the phosphoprotein of bovine respiratory syncytial
RT   virus required for N-P interaction using a two-hybrid system.";
RL   J. Gen. Virol. 77:1019-1023(1996).
RN   [4]
RP   INTERACTION WITH THE PHOSPHOPROTEIN, MUTAGENESIS OF LEU-3; CYS-48; CYS-156;
RP   CYS-162 AND LEU-391, AND FUNCTION.
RX   PubMed=10772994; DOI=10.1006/viro.2000.0264;
RA   Khattar S.K., Yunus A.S., Collins P.L., Samal S.K.;
RT   "Mutational analysis of the bovine respiratory syncytial virus nucleocapsid
RT   protein using a minigenome system: mutations that affect encapsidation, RNA
RT   synthesis, and interaction with the phosphoprotein.";
RL   Virology 270:215-228(2000).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH HOST NF-KAPPA-B.
RX   PubMed=32878896; DOI=10.1128/jvi.01380-20;
RA   Jobe F., Simpson J., Hawes P., Guzman E., Bailey D.;
RT   "Respiratory syncytial virus sequesters NF-kappaB subunit p65 to
RT   cytoplasmic inclusion bodies to inhibit innate immune signalling.";
RL   J. Virol. 0:0-0(2020).
CC   -!- FUNCTION: Encapsidates the viral RNA genome by forming a left-handed
CC       helical nucleocapsid that protects the RNA from nucleases (Probable).
CC       RNA replication depends on the availability of soluble nucleoprotein
CC       (By similarity). The encapsidated genomic RNA is termed the NC and
CC       serves as template for transcription and replication (By similarity).
CC       Together with the phosphoprotein, sequesters host NF-kappa-B in
CC       inclusion bodies (IBs) thereby inhibiting this host defense pathway
CC       (PubMed:32878896). May also act as a modulator of the innate immune
CC       response by sequestration of host IFIH1/MDA5 and MAVS into IBs (By
CC       similarity). {ECO:0000250|UniProtKB:P03418,
CC       ECO:0000269|PubMed:32878896, ECO:0000305|PubMed:10772994}.
CC   -!- SUBUNIT: Homomultimerizes to form the nucleocapsid (By similarity).
CC       Binds to viral genomic RNA (By similarity). Interacts with the
CC       phosphoprotein P (PubMed:8609467, PubMed:10772994). When in a monomeric
CC       RNA-free form, interacts with the phosphoprotein (via N-terminus) (By
CC       similarity). Interacts with protein M2-1; this interaction allows the
CC       association of nucleocapsid with the matrix protein (By similarity).
CC       Interacts with host EIF2AK2/PKR; this interaction inhibits EIF2AK2
CC       phosphorylation of EIF2S1 and blocks EIF2AK2-mediated translation
CC       shutoff (By similarity). Interacts with host EIF1AX; this interaction
CC       recruits EIF1AX to the viral replication complex to facilitate viral
CC       genomic RNA synthesis and virus production (By similarity). Interacts
CC       with host NF-kappa-B; this interaction sequesters NF-kappa-B in
CC       inclusion bodies (PubMed:32878896). {ECO:0000250|UniProtKB:P03418,
CC       ECO:0000269|PubMed:10772994, ECO:0000269|PubMed:32878896,
CC       ECO:0000269|PubMed:8609467}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000250|UniProtKB:P03418}. Host
CC       cytoplasm {ECO:0000269|PubMed:32878896}. Note=Localizes in cytoplasmic
CC       inclusion bodies. {ECO:0000269|PubMed:32878896}.
CC   -!- PTM: Tyrosine phosphorylation modulates viral transcription and
CC       replication. {ECO:0000250|UniProtKB:P03418}.
CC   -!- SIMILARITY: Belongs to the paramyxoviruses nucleocapsid family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M35076; AAA42812.1; -; mRNA.
DR   EMBL; AF295543; AAL49394.1; -; Genomic_RNA.
DR   EMBL; AF295544; AAL49405.1; -; Genomic_RNA.
DR   PIR; A38525; VHNZB4.
DR   SMR; P22677; -.
DR   DIP; DIP-1085N; -.
DR   IntAct; P22677; 1.
DR   Proteomes; UP000007616; Genome.
DR   GO; GO:0019029; C:helical viral capsid; IEA:UniProtKB-KW.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0039644; P:suppression by virus of host NF-kappaB cascade; IEA:UniProtKB-KW.
DR   GO; GO:0039580; P:suppression by virus of host PKR signaling; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0039554; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of host MDA-5 activity; IEA:UniProtKB-KW.
DR   GO; GO:0039545; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity; IEA:UniProtKB-KW.
DR   InterPro; IPR004930; Pneumo_ncap.
DR   Pfam; PF03246; Pneumo_ncap; 1.
PE   1: Evidence at protein level;
KW   Capsid protein; Helical capsid protein; Host cytoplasm;
KW   Host-virus interaction; Inhibition of host innate immune response by virus;
KW   Inhibition of host interferon signaling pathway by virus;
KW   Inhibition of host MAVS by virus; Inhibition of host MDA5 by virus;
KW   Inhibition of host NF-kappa-B by virus; Inhibition of host PKR by virus;
KW   Inhibition of host RLR pathway by virus; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Viral immunoevasion;
KW   Viral nucleoprotein; Virion.
FT   CHAIN           1..391
FT                   /note="Nucleoprotein"
FT                   /id="PRO_0000142648"
FT   REGION          1..364
FT                   /note="Involved in RNA synthesis and encapsidation"
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   REGION          244..290
FT                   /note="Interaction with the phosphoprotein"
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   REGION          338..364
FT                   /note="Interaction with the phosphoprotein"
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MOD_RES         38
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P03418"
FT   VARIANT         67
FT                   /note="I -> M (in strain: ATCC 51908)"
FT   VARIANT         213
FT                   /note="I -> F (in strain: ATCC 51908)"
FT   MUTAGEN         3
FT                   /note="L->A: Complete loss of encapsidation but no effect
FT                   on viral RNA synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         3
FT                   /note="L->E,K: About 80-95% inhibition of viral RNA
FT                   synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         3
FT                   /note="L->G: No effect on viral RNA synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         48
FT                   /note="C->S: About 80-95% inhibition of viral RNA
FT                   synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         156
FT                   /note="C->S: Complete loss of viral RNA synthesis and
FT                   encapsidation; when associated with S-162."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         162
FT                   /note="C->S: Complete loss of viral RNA synthesis and
FT                   encapsidation; when associated with S-156."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         391
FT                   /note="L->A,K: About 80-95% inhibition of viral RNA
FT                   synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
FT   MUTAGEN         391
FT                   /note="L->E,G: Complete loss of viral RNA synthesis."
FT                   /evidence="ECO:0000269|PubMed:10772994"
SQ   SEQUENCE   391 AA;  43445 MW;  F6729E09F02E7F8A CRC64;
     MALSKVKLND TFNKDQLLST SKYTIQRSTG DNIDIPNYDV QKHLNKLCGM LLITEDANHK
     FTGLIGILYA MSRLGREDTL KILKDAGYQV RANGVDVITH RQDVNGKEMK FEVLTLVSLT
     SEVQGNIEIE SRKSYKKMLK EMGEVAPEYR HDSPDCGMIV LCVAALVITK LAAGDRSGLT
     AVIRRANNVL RNEMKRYKGL IPKDIANSFY EVIEKYPHYI DVFVHFGIAQ SSTRGGSRVE
     GIFAGLFMNA YGAGQVMLRW GVLAKSVKNI MLGHASVQAE MEQVVEVYEY AQKLGGEAGF
     YHILNNPKAS LLSLTQFPNF SSVVLGNAAG LGIMGEYRGT PRNQDLYDAA KAYAEQLKEN
     GVINYSVLDL TTEELEAIKN QLNPKDNDVE L
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024